This paper gives an overview of economic assessments of the benefits of the control of 1-Methyl-2-pyrrolidone (NMP), an organic solvent, used in a number of sectors. Health risks associated with the manufacture of NMP include the risk of stillbirth and developmental retardation to pregnant workers, as well as a variety of chronic and acute effects, including respiratory effects.
Economic valuation in 1-Methyl-2-pyrrolidone (NMP) regulation
Working paper
OECD Environment Working Papers
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
24 October 2024
Related publications
-
12 September 2024